Cargando…
Transcription factor LSF (TFCP2) inhibits melanoma growth
Late SV40 factor 3 (LSF), a transcription factor, contributes to human hepatocellular carcinoma (HCC). However, decreased expression level of LSF in skin melanoma compared to that in benign melanocytic tumors and nevi in mice and humans was found in this study. Anchorage-dependent and -independent g...
Autores principales: | Goto, Yuji, Yajima, Ichiro, Kumasaka, Mayuko, Ohgami, Nobutaka, Tanaka, Asami, Tsuzuki, Toyonori, Inoue, Yuji, Fukushima, Satoshi, Ihn, Hironobu, Kyoya, Mikiko, Ohashi, Hiroyuki, Kawakami, Tamihiro, Bennett, Dorothy C., Kato, Masashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823042/ https://www.ncbi.nlm.nih.gov/pubmed/26506241 http://dx.doi.org/10.18632/oncotarget.6230 |
Ejemplares similares
-
RAS/RAF/MEK/ERK and PI3K/PTEN/AKT Signaling in Malignant Melanoma Progression and Therapy
por: Yajima, Ichiro, et al.
Publicado: (2012) -
Factor quinolinone inhibitors disrupt spindles and multiple LSF (TFCP2)-protein interactions in mitosis, including with microtubule-associated proteins
por: Yunes, Sarah A., et al.
Publicado: (2022) -
Hair graying with aging in mice carrying oncogenic RET
por: Iida, Machiko, et al.
Publicado: (2020) -
Manganese-mediated acceleration of age-related hearing loss in mice
por: Ohgami, Nobutaka, et al.
Publicado: (2016) -
Molecular Network Associated with MITF in Skin Melanoma Development and Progression
por: Yajima, Ichiro, et al.
Publicado: (2011)